Mollick Darren K MD is categorized under Physicians Offices in Smithtown, NY and active since 2007.
Mollick Darren K MD was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Darren Mollick at the company’s single location by writing to 994 West Jericho Turnpike # 103, Smithtown, New York NY 11787 or by phoning (631) 864-6647. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Mollick Darren K MD |
| Contact Person: | Darren Mollick |
| Address: | 994 West Jericho Turnpike # 103, Smithtown, New York 11787 |
| Phone Number: | (631) 864-6647 |
| Website Address: | liskincancer.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physicians Offices |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Mollick Darren K MD was started in 2007 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Darren Mollick for inquiries that concern Mollick Darren K MD by calling the company number (631) 864-6647, as your correspondence is most welcome. Additionally, the physical location of the single location of Mollick Darren K MD can be found at the coordinates 40.84771,-73.25078 as well as the street address 994 West Jericho Turnpike # 103 in Smithtown, New York 11787.
For its online presence, you may visit Mollick Darren K MD’s website at liskincancer.com and engage with its social media outlets through on Twitter and on Facebook.